gregg-lapointe.jpg

Gregg Lapointe, MBA, CPA

Gregg Lapointe’s background includes extensive experience in the areas of global strategic planning, business development, corporate finance, licensing and acquisitions. He previously served in varying roles for Sigma-Tau Pharmaceuticals, Inc., a private biopharmaceutical company, starting in 2001, including Chief Financial Officer from 2001 to 2002, Chief Operating Officer from 2003 to 2007, and Chief Executive Officer from 2008 to 2012. Mr. Lapointe led the effort to transform Sigma-Tau Pharmaceuticals from a small specialty dialysis company into a global leader in the development and commercialization of medicines for Rare Diseases.

He serves on the Board of Directors of SciClone Pharmaceuticals, Inc., Soligenix, Inc., Raptor Pharmaceutical Corp., and the Board of Trustees of the Keck Graduate Institute of Applied Life Science.  Mr. Lapointe previously served on the Board of Directors of Questcor Pharmaceuticals, Inc. and the Pharmaceuticals Research and Manufacturers of America (PhRMA).  He holds  a Bachelor of Commerce degree from Concordia University (Montreal), a Graduate Diploma in Public Accountancy from McGill University (Montreal), an MBA from Duke University, and is a CPA (Illinois).

Brian S..jpg

Brian Schreiber, MD 

Dr. Brian Schreiber is a Board Certified Nephrologist with extensive industry experience in medical affairs and assessing new product opportunities, specializing in rare diseases. Previously, Dr. Schreiber served as Vice President of Medical Development at Relypsa Pharmaceuticals and spent 14 years with Sigma-Tau Pharmaceuticals as the head of its Medical Affairs department. Prior to joining Sigma-Tau, Dr. Schreiber served as Chief Medical Director of Dialysis Care Inc., a multi-center dialysis chain providing services in northeast and central Wisconsin and continues to remain active in this capacity. He was also Chairman of Nephrology at LaSalle Clinic, Affinity Medical System for five years prior to establishing Fox Valley Nephrology as a joint venture between Affinity Medical Group and Thedacare Health systems. He served as its first president until 2001. During this time Dr. Schreiber served as a medical consultant to Sigma-Tau. Dr. Schreiber has continued his activities in academia, having been appointed as an Assistant Clinical Professor of Medicine, Department of Medicine, Division of Nephrology, Medical College of Wisconsin, Milwaukee, Wisconsin.

He has published a variety of academic papers including original research, review articles, and a textbook chapter on inflammation and renal disease and has given numerous lectures and symposia in academic settings.

nancy-klett.jpg

Nancy Klett, MPH

Nancy Klett is a Human Resources, Project Management and Patient Relations professional with over 10 years of experience contributing to projects in the pharmaceutical, hospitality and public health industries. She is a solutions-oriented individual with the ability to communicate with all levels of management. Nancy is able to leverage her Project Management expertise to align day-to-day operations with business goals and objectives. Nancy served in various roles at Sigma-Tau starting in 2002 as a Patient-Relations advocate and then moving into the Human Resources and Project Management fields. In 2010 Nancy became the Senior Director of Human Resources at Sigma-Tau. Nancy holds a Master’s degree in Public Health and a Bachelor of Science from The George Washington University in Washington, DC.